Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers …………… Philippou S, Mastroyiannopoulos NP, Makrides N, Lederer CW, Kleanthous M, Phylactou LA. MolTher Nucleic Acids. 2018 Mar 2;10:199-214. PubMed 00
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma …………… Esposito CL, Nuzzo S, Catuogno S, Romano S, de Nigris F, de Franciscis V. MolTher Nucleic Acids. 2018 Mar 2;10:398-411. PubMed 00
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer …………… Yu X, Ghamande S, Liu H, Xue L, Zhao S, Tan W, Zhao L, Tang SC, Wu D, Korkaya H, MolTher Nucleic Acids. 2018 Mar 2;10:317-330. PubMed 00
A DNA thioaptamer with homing specificity to lymphoma bone marrow involvement …………… Mai J, Li X, Zhang G, Huang Y, Xu R, Shen Q, Lokesh GLR, Thiviyanathan V, Chen L, Liu H, Zu Y, Ma X, Volk DE, Gorenstein DG, Ferrari M, Shen H. Mol Pharm. 2018 Mar 14. PubMed 00